Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Applying to Washington University School of Medicine · St Louis, Missouri
Answer a few short questions to share with the research team.